Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127186721 | 12718672 | 1 | I | 2013 | 20160826 | 20160906 | 20160906 | EXP | US-GLAXOSMITHKLINE-US2016125153 | GLAXOSMITHKLINE | 64.06 | YR | F | Y | 0.00000 | 20160906 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127186721 | 12718672 | 1 | PS | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 1.5 MG, U | Y | UNKNOWN | 20658 | 1.5 | MG | TABLET | |||||
| 127186721 | 12718672 | 2 | SS | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | 3 MG, U | Y | 20658 | 3 | MG | TABLET | |||||||
| 127186721 | 12718672 | 3 | SS | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | .75 MG, U | Y | 20658 | .75 | MG | TABLET | |||||||
| 127186721 | 12718672 | 4 | SS | ROPINIROLE HYDROCHLORIDE. | ROPINIROLE HYDROCHLORIDE | 1 | UNK UNK, U | Y | UNKNOWN | 20658 | |||||||||
| 127186721 | 12718672 | 5 | SS | NEUPRO | ROTIGOTINE | 1 | UNK UNK, U | Y | UNKNOWN | 0 | |||||||||
| 127186721 | 12718672 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | U | 0 | INHALATION POWDER | ||||||||||
| 127186721 | 12718672 | 7 | C | LEVOTHYROXIN | LEVOTHYROXINE | 1 | U | 0 | |||||||||||
| 127186721 | 12718672 | 8 | C | PRAVASTATIN. | PRAVASTATIN | 1 | U | 0 | |||||||||||
| 127186721 | 12718672 | 9 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127186721 | 12718672 | 1 | Restless legs syndrome |
| 127186721 | 12718672 | 4 | Restless legs syndrome |
| 127186721 | 12718672 | 5 | Restless legs syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127186721 | 12718672 | HO |
| 127186721 | 12718672 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127186721 | 12718672 | Blood cholesterol increased | |
| 127186721 | 12718672 | Bronchitis | |
| 127186721 | 12718672 | Bronchospasm | |
| 127186721 | 12718672 | Chronic obstructive pulmonary disease | |
| 127186721 | 12718672 | Cough | |
| 127186721 | 12718672 | Dysphagia | |
| 127186721 | 12718672 | Dyspnoea | |
| 127186721 | 12718672 | Insomnia | |
| 127186721 | 12718672 | Lung disorder | |
| 127186721 | 12718672 | Lung infection | |
| 127186721 | 12718672 | Lung infiltration | |
| 127186721 | 12718672 | Oxygen saturation decreased | |
| 127186721 | 12718672 | Pleural effusion | |
| 127186721 | 12718672 | Pleural thickening | |
| 127186721 | 12718672 | Respiratory tract infection | |
| 127186721 | 12718672 | Sinus congestion | |
| 127186721 | 12718672 | Thyroid disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127186721 | 12718672 | 1 | 2009 | 0 | ||
| 127186721 | 12718672 | 2 | 201601 | 0 | ||
| 127186721 | 12718672 | 5 | 201606 | 0 |